Nov 3 2017 15:30
The UK should invest hundreds of millions of pounds in high-risk research programs and “moon shot” projects, according to a report on the Government's new Life Sciences Industrial Strategy. The report calls for investment in fields such as genomics, artificial intelligence, and digital health, to help pave the way for the emergence of entirely new industries in the UK over the next ten years.
Such a vision requires sustained funding for science and infrastructure, as well as supporting formation of stronger strategic partnerships between universities, industry, and the NHS.
Featuring presentations from well-placed guest speakers and audience discussion, this seminar will explore the opportunities and challenges for Oxford’s Biomedical Research Centre, Academic Health Science Centre, and Academic Health Science Network in helping to realize these ambitious goals in Oxford and the surrounding region. Speakers: Dr Glenn Wells, Chief Operating Officer, Oxford Academic Health Science Centre Dr Nick Scott-Ram, Director of Commercial Development, Oxford Academic Health Science Network Chair: Professor Trish Greenhalgh, Nuffield Department of Primary Care Health Sciences, University of Oxford The seminar is co-organized by Partnership for Health Wealth and Innovation, Oxford BRC, and Health Policy and Systems Network, Green Templeton College. Image: Pixabay
For details, link here: https://www.eventbrite.co.uk/e/the-new-uk-life-sciences-strategy-implications-for-the-oxford-regional-innovation-system-tickets-38038147122